FDA warns Immusist that it is selling unapproved and misbranded new drugs.
Politico reports that FDA and other health agencies are trying to fight an Executive Order that could make it easier for the Trump administration to f...
FDA warns the Young Foundational Health Center that it is illegally marketing stem cell products for a variety of diseases and conditions.
FDA reminds laboratories and healthcare providers that false positives can occur with antigen tests being used for the rapid detection of SARS-CoV-2.
FDA approves updated prescribing information for Emmaus Life Sciences Endari (L-glutamine oral powder) to better inform healthcare professionals and s...
Law professor Dorit Reiss outlines ways Congress could restructure FDA to make it better able to withstand political pressure on product approvals.
Federal Register notice: FDA sends to OMB an information collection extension for Generic Clearance for the Collection of Qualitative Feedback on Agen...
Federal Register notice: FDA sends to OMB an information collection extension for Exceptions or Alternatives to Labeling Requirements for Products Hel...